Follow the HeartWare International, Inc. share price and the full insider trade history of the company, a publicly traded company based in United States. Shares are listed on the US market, under the supervision of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was filed on 9 February 2016 (Levée d'options). Among the most active insiders: Schuermann James. All data is free.
21
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
16 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate HeartWare International, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
Fundamental score
Ranked 24,422 of 28,686 companies
26.6
score / 100
Value
23
Quality
31
FCF yld-4.0%
Earn yld-5.1%
EV/EBITDA·
ROE-40%
Gross mgn63%
Net mgn-47%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
HeartWare International, Inc. is a company focused on developing medical devices for the treatment of heart diseases. It primarily concentrates on cardiac support systems for patients with heart failure.